Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 studyXinxin Cao, Daobin Zhou, Guohui Cui et al.|EClinicalMedicine|2022Cited by 43
Pooled Analysis of Safety Data from Clinical Trials of Orelabrutinib Monotherapy in Hematologic MalignanciesYuqin Song, Jun Zhu, Wei Xu et al.|Blood|2020Cited by 16
Efficacy and Safety of Orelabrutinib in Relapsed/Refractory Waldenstrom's Macroglobulinemia PatientsDaobin Zhou, Xiangyang Zhang, Jie Jin et al.|Blood|2021Cited by 11
Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenström's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up ResultsXinxin Cao, Daobin Zhou, Jie Jin et al.|Blood|2023Cited by 4
[The value of chest computerized tomography in evaluation of bone disease and clinical prognosis of multiple myeloma].Wenjiao Tang, Junling Zhuang, Yi Da et al.|PubMed|2015Cited by 2